Recognition of R&D Expenses
First written in FY2021-Q3. 14 of 17 entries say "Restated". Latest entry: FY2026.
8 other companies' latest entry also says "Advanced".
- FY2026AdvancedAnnual report
「The Group's total research and development expenses for the consolidated fiscal year were ¥123.026 million.」
Research and development expenses were ¥123.026 million, up from ¥119.755 million in the previous fiscal year. - FY2026-H1RestatedAnnual report
「Total research and development expenses for the interim consolidated accounting period under review were ¥61 million.」
The Company continued its research and development activities during the interim consolidated accounting period under review and recorded research and development expenses of ¥61 million. - FY2025RestatedAnnual report
「The Group's total research and development expenses for the consolidated fiscal year were ¥119.755 million.」
The Company continued its research and development activities and disclosed full-year research and development expenses of ¥119.755 million, down from ¥134.705 million in the previous fiscal year. - FY2024RestatedAnnual report
「The total research and development expenses incurred by the Group during the consolidated fiscal year were ¥134.705 million.」
The Company continued its research and development activities and disclosed full-year research and development expenses of ¥134.705 million. - FY2024-Q3RestatedAnnual report
「Total research and development expenses for the cumulative third quarter ended period under review were ¥102 million.」
The Company reaffirmed its research and development activities for the cumulative third quarter ended period under review and recorded research and development expenses of ¥102 million. - FY2024-Q2RestatedAnnual report
「Total research and development expenses for the cumulative second quarter ended period under review were ¥67 million.」
The Company continued its research and development activities and disclosed total research and development expenses of ¥67 million for the cumulative second quarter ended period under review. - FY2024-Q1RestatedAnnual report
「Total research and development expenses for the cumulative first quarter ended period under review were ¥33 million.」
The Company continued its research and development activities and disclosed total first-quarter research and development expenses of ¥33 million. - FY2023AdvancedAnnual report
「The total research and development expenses incurred by the Group during the consolidated fiscal year were ¥136.722 million.」
Research and development expenses were ¥136.722 million, up from ¥105.557 million in the previous fiscal year. The Company also reported development of new products, including a new sensor-operated faucet and an ultrafine-bubble showerhead. - FY2023-Q3RestatedAnnual report
「Total research and development expenses for the cumulative third quarter ended period under review were ¥106 million.」
The Company reaffirmed its continuation of research and development activities, with total research and development expenses for the cumulative third quarter ended period under review of ¥106 million. - FY2023-Q2RestatedAnnual report
「Total research and development expenses for the cumulative second quarter ended period under review were ¥74 million.」
Total research and development expenses for the cumulative second quarter ended period under review were ¥74 million. - FY2023-Q1RestatedAnnual report
「Total research and development expenses for the cumulative first quarter ended period under review were ¥35 million.」
Total research and development expenses for the cumulative first quarter ended period under review were ¥35 million. - FY2022RestatedAnnual report
「The total research and development expenses incurred by the Group during the consolidated fiscal year were ¥105.557 million.」
Research and development expenses for the fiscal year ended March 2022 were ¥105.557 million, and research and development activities continued. - FY2022-Q3RestatedAnnual report
「Total research and development expenses for the third quarter of the current consolidated cumulative period were ¥81 million.」
Total research and development expenses for the cumulative third quarter ended period under review were ¥81 million. - FY2022-Q2RestatedAnnual report
「Total research and development expenses for the cumulative second quarter ended period under review were ¥58 million.」
Total research and development expenses for the cumulative second quarter ended period under review were ¥58 million. - FY2022-Q1RestatedAnnual report
「Total research and development expenses for the cumulative first quarter ended period under review were ¥31 million.」
Total research and development expenses in the first quarter were ¥31 million. - FY2021RestatedAnnual report
「The total research and development expenses incurred by the Group during the consolidated fiscal year were ¥150.822 million.」
Full-year research and development expenses were ¥150.822 million. Research and development continued, focusing mainly on electronic devices, key components, and materials research. - FY2021-Q3First statedAnnual report
「Total research and development expenses for the cumulative third quarter ended period under review were ¥124 million.」
Total research and development expenses for the cumulative third quarter ended period under review were ¥124 million.